July, 2021, Plaintiff came across a product, "ZUMO Nimesulide
and Paracetamol" tablets [hereinafter "impugned product"] being sold by
Defendants, bearing ... Plaintiff
and Defendants, contain the same ingredients i.e., Nimesulide and
Paracetamol, and are prescribed as painkillers to patients.
15.4. Defendant No. 1, Scott Edil
search of the House yielded 9kg of red stone, 24kg of paracetamol, 1.6kg of
'power', 5kg of phenobarbital, 2kg of mixed substances
same product, namely medicinal
preparations such as Nimesulide and Paracetamol tablets. DRL asserts that
Pureca's actions constitute infringement, passing off and unfair competition ... infringing activities: In June 2020, DRL learnt of
Nimesulide and Paracetamol preparations being sold under the mark 'NISE-
P' ["infringing mark
from the first letters of
the product's constituent elements - Diclofenac, Paracetamol, and
Serratiopeptidase. This unique nomenclature serves as a distinctive
identifier, distinguishing
derivative variants, which are utilised for
pharmaceutical preparations containing ibuprofen and paracetamol tablets.
They have instituted the present lawsuit alleging that the Defendants are
infringing
